Publications
-
Low Vitamin-D levels combined with PKP3-SIGIRR-TMEM16J host variants is associated with tuberculosis
Citation: Gupta A, Montepiedra G, Gupte A, Jubulis J, Zeldow B, Detrick B, Violari A, Madhi SA, Bobat R, Cotton MF, Mitchell C, Spector SA, for the IMPAACT NWCS113 and P1041 Study Team.Low Vitamin-D levels combined with PKP3-SIGIRR-TMEM16J host variants is associated with tuberculosis in HIV-infected and exposed infants. PLoS One. 2016 Feb 12;11(2):e0148649. doi: 10.1371/journal.pone.0148649. eCollection 2016. PMID: 26872154. PMCID: PMC4752266.
Date: 02/12/2016
Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual
Citation: Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, Chege W, Postle BS, Matheson T, Amico KR, Ziegler T, Rawlings MK, Trainor N, Blue RW, Estrada W, Coleman ME, Cardenas G, Feaster DJ, Grant R, Philip SS, Elion R, Buchbinder S, Kolber MA. Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016 Jan;176(1):75-84. doi: 10.1001/jamainternmed.2015.4683. PMID: 26571482. PMCID: PMC5042323.
Date: 01/15/2016
Cost effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India
Citation: Kapoor S, Gupta A, Shah M. Cost effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India. Int J Tuberc Lung Dis. 2016 Jan;20(1):85-92. doi: 10.5588/ijtld.15.0391. PMID: 26688533. PMCID: PMC4992362.
Date: 01/15/2016
Dose frequency ranging pharmacokinetic study of tenofovir-emtricitabine after directly observed
Citation: Hendrix CW, Andrade A, Bumpus NN, Kashuba AD, Marzinke MA, Moore A, Anderson PL, Bushman LR, Fuchs EJ, Wiggins I, Radebaugh C, Prince HA, Bakshi RP, Wang R, Richardson P, Shieh E, McKinstry L, Li X, Donnell D, Elharrar V, Mayer KH, Patterson KB.Dose frequency ranging pharmacokinetic study of tenofovir-emtricitabine after directly observed dosing in healthy volunteers to establish adherence benchmarks (HPTN 066). AIDS Res Hum Retroviruses. 2016 Jan;32(1):32-43. doi: 10.1089/AID.2015.0182. Epub 2015 Oct 15.
Date: 01/15/2016
Pediatric tuberculous meningitis: model-based approach to determining optimal doses of the
Citation: Savic RM, Ruslami R, Hibma JE, Hesseling A, Ramachandran G, Ganiem AR, Swaminathan S, McIlleron H, Gupta A, Thakur K, van Crevel R, Aarnoutse R, Dooley KE. Pediatric tuberculous meningitis: model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children. Clin Pharmacol Ther. 2015 Dec;98(6):622-9. doi: 10.1002/cpt.202. Epub 2015 Oct 22. PMID: 26260983. PMCID: PMC4888594.
Date: 12/15/2015
HIV salvage therapy does not require nucleoside reverse transcriptase inhibitors: A randomized,
Citation: Tashima KT, Smeaton LM, Fichtenbaum CJ, Andrade A, Eron JJ, Gandhi RT, Johnson VA, Klingman KL, Ritz J, Hodder S, Santana JL, Wilkin T, Haubrich RH; A5241 Study Team. HIV salvage therapy does not require nucleoside reverse transcriptase inhibitors: A randomized, controlled trial. Ann Intern Med. 2015 Dec 15;163(12):908-17. doi: 10.7326/M15-0949. Epub 2015 Nov 24. PMID: 26595748. PMCID: PMC4681296.
Date: 12/15/2015
Changing trends in complications and mortality rates among US youth and young adults with HIV
Citation: Mirani G, Williams PL, Chernoff M, Abzug MJ, Levin MJ, Seage GR 3rd, Oleske JM, Purswani MU, Hazra R, Traite S, Zimmer B, Van Dyke RB; IMPAACT P1074 Study Team. Changing trends in complications and mortality rates among US youth and young adults with HIV infection in the era of combination antiretroviral therapy. Clin Infect Dis. 2015 Dec 15;61(12):1850-61. doi: 10.1093/cid/civ687. Epub 2015 Aug 12. PMID: 26270680; PMCID: PMC4657532
Date: 12/15/2015
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases
Citation: Andrade A, Guedj J, Rosenkranz SL, Lu D, Mellors J, Kuritzkes DR, Perelson AS, Ribeiro RM; ACTG A5249s protocol team. Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b). AIDS. 2015 Nov 28;29(18):2419-26. doi: 10.1097/QAD.0000000000000843. PMID: 26558541. PMCID: PMC4646723.
Date: 11/28/2015
A tailored approach to launch community coalitions focused on achieving structural changes: Lessons
Citation: Chutuape KS, Willard N, Walker BC, Boyer CB, Ellen J; Adolescent Medicine Trials Network for HIVAIDS Interventions. A tailored approach to launch community coalitions focused on achieving structural changes: Lessons learned from a HIV prevention mobilization study. J Public Health Manag Pract. 2015 Nov-Dec;21(6):546-55. doi: 10.1097/PHH.0000000000000182. PMID: 26785397; PMCID: PMC4721266
Date: 11/01/2015
CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of
Citation: Fairlie L, Karalius B, Patel K, van Dyke RB, Hazra R, Hernán MA, Siberry GK, Seage GR 3rd, Agwu A, Wiznia A; Pediatric HIV AIDS Cohort Study (PHACS), The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT). CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States. AIDS. 2015 Oct 23;29(16):2109-19. doi: 10.1097/QAD.0000000000000809. PMID: 26182197; PMCID: PMC4612147
Date: 10/23/2015
- ‹ First < 13 14 15 16 17 > Last ›